Treatment | Revenue (USD) | Total variable cost (USD) | Net benefit (USD) |
Panel A - 2021 BCR analysis | |||
Control | 517.95 | 404.06 | 113.89 |
Full OFA | 977.80 | 420.48 | 557.31 |
Full NPK | 1203.43 | 623.57 | 579.86 |
½ OFA + ½ NPK | 1161.87 | 517.47 | 644.39 |
Full OFA + ½ NPK | 1347.67 | 521.13 | 826.54 |
Panel B - 2022 BCR analysis | |||
Control | 414.75 | 358.59 | 56.16 |
Full OFA | 672.51 | 373.16 | 299.35 |
Full NPK | 1708.70 | 638.53 | 1070.17 |
½ OFA + ½ NPK | 1547.60 | 459.23 | 1088.36 |
Full OFA + ½ NPK | 1435.17 | 462.48 | 972.69 |